147 related articles for article (PubMed ID: 20604764)
1. A case of tongue carcinoma associated with chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Noguchi K; Nakase M; Inui M; Nakamura S; Okumura K; Tagawa T
Aust Dent J; 2010 Jun; 55(2):200-2. PubMed ID: 20604764
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Szeto CH; Shek TW; Lie AK; Au WY; Yuen AP; Kwong YL
Am J Hematol; 2004 Oct; 77(2):200-2. PubMed ID: 15389910
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature.
Demarosi F; Soligo D; Lodi G; Moneghini L; Sardella A; Carrassi A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
5. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
6. Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.
Messina G; Quartarone E; Console G; Cuzzola M; Iacopino O; Martino M; Irrera G; Morabito F; Iacopino P
Haematologica; 2002 Jul; 87(7):ECR22. PubMed ID: 12091138
[TBL] [Abstract][Full Text] [Related]
7. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
Masserot C; Peffault de Latour R; Rocha V; Leblanc T; Rigolet A; Pascal F; Janin A; Soulier J; Gluckman E; Socié G
Cancer; 2008 Dec; 113(12):3315-22. PubMed ID: 18831513
[TBL] [Abstract][Full Text] [Related]
8. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
9. Multiple squamous cell carcinomas of the oral cavity in a young patient with graft-versus-host disease following allogenic bone marrow transplantation.
Montebugnoli L; Gissi DB; Marchetti C; Foschini MP
Int J Oral Maxillofac Surg; 2011 May; 40(5):556-8. PubMed ID: 21163622
[TBL] [Abstract][Full Text] [Related]
10. Oral malignancies following HSCT: graft versus host disease and other risk factors.
Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A
Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of oral chronic graft-versus-host disease.
Treister NS; Cook EF; Antin J; Lee SJ; Soiffer R; Woo SB
Biol Blood Marrow Transplant; 2008 Jan; 14(1):110-5. PubMed ID: 18158967
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma.
Seropian S; Bahceci E; Cooper DL
Bone Marrow Transplant; 2003 Oct; 32(8):763-9. PubMed ID: 14520419
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
Uberti JP; Ayash L; Braun T; Reynolds C; Silver S; Ratanatharathorn V
Bone Marrow Transplant; 2004 Sep; 34(5):425-31. PubMed ID: 15273705
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.
Schetelig J; Kröger N; Held TK; Thiede C; Krusch A; Zabelina T; Dubiel M; Rick O; Bornhäuser M; Ehninger G; Zander AR; Siegert W
Haematologica; 2002 Mar; 87(3):299-305. PubMed ID: 11869943
[TBL] [Abstract][Full Text] [Related]
15. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
[TBL] [Abstract][Full Text] [Related]
16. Optimal management of chronic graft-versus-host disease in children.
Jacobsohn DA
Br J Haematol; 2010 Aug; 150(3):278-92. PubMed ID: 20553274
[TBL] [Abstract][Full Text] [Related]
17. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series.
Sturgis EM; Moore BA; Glisson BS; Kies MS; Shin DM; Byers RM
Head Neck; 2005 Sep; 27(9):748-56. PubMed ID: 16086413
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation.
Nouri-Majelan N; Sanadgol H; Ghafari A; Rahimian M; Najafi F; Mortazavizadeh M; Moghaddasi S
Transplant Proc; 2005 Sep; 37(7):3213-5. PubMed ID: 16213351
[TBL] [Abstract][Full Text] [Related]
20. 'GVHD': graft-versus-host disease or graft-versus-Hodgkin's disease? An old acronym with new meaning.
Porter DL; Stadtmauer EA; Lazarus HM
Bone Marrow Transplant; 2003 May; 31(9):739-46. PubMed ID: 12732878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
